ANTIANGIOGENIC GENE THERAPY WITH SOLUBLE VEGFR-2 AND TIE2 REDUCES THE GROWTH OF HUMAN OVARIAN CARCINOMA IN MICE

被引：0
|
作者：
Tuppurainen, L. [1 ]
Sallinen, H. [2 ]
Karvonen, A. [1 ]
Hakkarainen, H. [3 ]
Liimatainen, T. [3 ]
Hytonen, E. [1 ]
Hamalainen, K. [4 ]
Kosma, V. M. [4 ]
Anttila, M. [2 ]
Alitalo, K. [5 ,6 ]
Yla-Herttuala, S. [1 ]
机构：
[1] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Gynecol, SF-70210 Kuopio, Finland
[3] Univ Eastern Finland, NMR Res Grp, AI Virtanen Inst Mol Sci, Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland
[5] Univ Helsinki, Mol Canc Biol Lab, Biomedicum Helsinki, Helsinki, Finland
[6] Univ Helsinki, Haartman Inst, Helsinki, Finland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1277
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [41] Expression and localization of VEGFR-2 in hair follicles during induced hair growth in mice
    Xian-Jie Wu
    Jing Jing
    Zhong-Fa Lu
    Min Zheng
    Archives of Dermatological Research, 2018, 310 : 591 - 598
  • [42] Antiangiogenic gene therapy delays growth of murine and human pancreatic adenocarcinoma in mice
    Tseng, JF
    Farnebo, FA
    Kisker, O
    Becker, CM
    Kuo, CJ
    Folkman, J
    Mulligan, RC
    GASTROENTEROLOGY, 2001, 120 (05) : A349 - A349
  • [43] Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH
    A Aweimer
    T Stachon
    A Tannapfel
    M Köller
    M C Truss
    A Stachon
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 157 - 164
  • [44] Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH
    Aweimer, A.
    Stachon, T.
    Tannapfel, A.
    Koeller, M.
    Truss, M. C.
    Stachon, A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (02) : 157 - 164
  • [45] SOLUBLE VEGFR-2 SERUM MAY BE A PREDICTIVE FACTOR FOR PROGRESSION OF CHRONIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA
    Ratnasari, N.
    Nurdjanah, S.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S100 - S100
  • [46] Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: In implication for angiogenesis
    Moon, WS
    Park, HS
    Yu, KH
    Jang, KY
    Kang, MJ
    Park, H
    Tarnawski, AS
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2006, 21 (02) : 272 - 278
  • [47] Gene therapy of cancer using an AAV serotype 2-mediated gene delivery system containing different combinations of antisense VEGF-A cDNA, truncated soluble VEGFR-1, and truncated soluble VEGFR-2 cDNA
    Park, K
    Hwang, SY
    Cho, YH
    Kim, YJ
    Lee, YI
    Cho, SH
    Yi, SY
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 610 - 610
  • [48] Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy
    Rojas, Juan D.
    Lin, Fanglue
    Chiang, Yun-Chen
    Chytil, Anna
    Chong, Diana C.
    Bautch, Victoria L.
    Rathmell, W. Kimryn
    Dayton, Paul A.
    THERANOSTICS, 2018, 8 (01): : 141 - 155
  • [49] Targeting the Hprt locus in mice reveals differential regulation of Tie2 gene expression in the endothelium
    Evans, V
    Hatzopoulos, A
    Aird, WC
    Rayburn, HB
    Rosenberg, RD
    Kuivenhoven, JA
    PHYSIOLOGICAL GENOMICS, 2000, 2 (02) : 67 - 75
  • [50] In vivo expression of an adenoviral vector encoding soluble tie2 inhibits metastatic hepatic tumor growth
    S. Sarraf-Yazdi
    J. Mi
    C. Kontos
    M. Dewhirst
    B. Clary
    Annals of Surgical Oncology, 2004, 11 : S56 - S56
12345